Search for: "Noven Pharmaceuticals, Inc."
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
14 Oct 2011, 6:10 pm
Orange County - Noven Pharmaceuticals, Inc. has filed an action for patent infringement against Watson Pharmaceuticals, Inc. in a federal district court in New Jersey. [read post]
4 Apr 2017, 9:59 pm
Noven Pharmaceuticals Inc., the Federal Circuit responded in the negative. [read post]
5 Apr 2017, 9:08 am
With respectto Watson, the PTAB found that it “does not controlhere because [Appellee] Noven [Pharmaceuticals Inc. [read post]
7 Apr 2013, 9:37 pm
Noven Pharmaceuticals Inc. et al. 1:13-cv-00527; filed April 3, 2013 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
3 Feb 2014, 9:51 pm
Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical, LTD; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
22 May 2017, 9:22 am
Noven Pharmaceuticals, Inc., which affirmed the Patent Trial and Appeal Board (PTAB) invalidation of claims in related inter partes review (IPR) proceedings. [read post]
22 Aug 2018, 7:21 am
" Noven Pharmaceuticals, Inc. v. [read post]
4 Apr 2014, 9:32 am
On March 19, 2014, Actavis plc (NYSE: ACT) announced that it entered into an agreement with Noven Pharmaceuticals, Inc. to settle all outstanding patent litigation related to Actavis’ generic version of Daytrana® (Methylphenidate Transdermal System). [read post]
28 Aug 2014, 5:09 pm
Jon LaPook presented the story, which suggested that the motivation was the continued patent coverage on Namenda XR.Forest had made an announcement on February 14, 2014: Forest Laboratories, Inc. [read post]
26 Aug 2008, 6:34 am
From various sites:Noven Pharmaceuticals Inc. said its partner Shire Ltd. is voluntarily recalling two lots of the attention deficit hyperactivity disorder drug patch Daytrana because of a problem with the patch liner.In the recalled lots, the liner that needs to be released before the patch can be applied does not meet specifications, meaning patients might have difficulty removing the liner in order to apply the drug. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
